President Donald Trump’s administration on Tuesday rolled out an executive action aimed at limiting direct-to-consumer advertising for pharmaceuticals, with officials saying a recent Hims & Hers Health Inc. ad stood out as an example of what should be prevented.
Trending
- $1.06 Billion in Days: Ethereum Just Flashed Crucial Market Signal
- Rain Raises $250M Series C To Scale Stablecoin-Powered Payments Infrastructure For Global Enterprises
- PattiePump Swap Announces Groundbreaking PAPPE Token Supply & Distribution Platform Launch
- Coinlocally Launches Reward Campaign Focused on User Engagement
- Daily Spotlight: Global Stocks Were Leaders in 2025
- Top Crypto Airdrops to Look Out for in 2026
- When You Look Into The Transition To New Crypto-based Projects
- How To Choose The App For Crypto Trading In Bitcoin And Trade Safely
